Recent Quotes

Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.

Earnings

Q1 2021		Est.		Actual		Surprise
EPS				-0.040
REV				0

Q4 2020		Est.		Actual		Surprise
EPS				-0.010
REV				510.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
COCP	Cocrystal Pharma	1.37	0.12	9.2%		133M

Cocrystal Pharma Frequently Asked Questions

How do I buy Cocrystal Pharma (COCP) stock?

You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.

View our list of the best stock brokerages.

Who are Cocrystal Pharma's (COCP) competitors?

Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA), Ocuphire Pharma (NASDAQ:OCUP) and Lipocine (NASDAQ:LPCN).

What is the target price for Cocrystal Pharma (COCP) stock?

The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on November 12, 2020. The analyst firm set a price target for 4.50 expecting COCP to rise to within 12 months (a possible 229.67% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Cocrystal Pharma (COCP)?

The stock price for Cocrystal Pharma (NASDAQ: COCP) is $1.365 last updated Today at 7:26:00 PM.

Does Cocrystal Pharma (COCP) pay a dividend?

There are no upcoming dividends for Cocrystal Pharma.

When is Cocrystal Pharma (NASDAQ:COCP) reporting earnings?

Cocrystal Pharma’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Cocrystal Pharma (COCP) going to split?

There is no upcoming split for Cocrystal Pharma.

What sector and industry does Cocrystal Pharma (COCP) operate in?

Cocrystal Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.